XRP rallied 5% after the Senate Banking Committee advanced the CLARITY Act, a bill designed to clarify crypto regulatory frameworks. The move reignited optimism that explicit legal standards could unlock institutional capital flows into XRP-linked products.
The CLARITY Act addresses longstanding ambiguity around crypto asset classification. By defining which digital assets qualify as securities versus commodities, the legislation targets regulatory friction that has constrained institutional adoption. XRP holders view the bill as particularly favorable, given the ongoing SEC lawsuit against Ripple Labs over whether XRP itself qualifies as a security. Legislative clarity could sideline that dispute entirely.
XRP's outperformance versus Bitcoin on the news reflects market perception that regulatory certainty disproportionately benefits altcoins with murky legal status. Bitcoin operates in clearer regulatory territory. XRP, by contrast, faces persistent institutional hesitation due to the SEC case and classification uncertainty. A CLARITY Act passage would remove that headwind.
However, advancing through a Senate committee remains far from final passage. The bill still faces House votes and potential opposition before becoming law. Market participants acknowledge the gap between committee approval and actual legal change. Institutional capital typically enters only after legislation clears both chambers and faces no reversal risk.
Ripple's XRP token trades in the $2.40 range currently, holding gains from the committee vote. The token's correlation with regulatory developments has strengthened over recent quarters. Other altcoins with questionable security status, including Cardano and Solana, also moved higher on the news.
The broader pattern shows crypto markets repricing around regulatory clarity expectations. For XRP specifically, the path to real institutional inflows runs through Congress, not committee votes. Until full legislative passage occurs, the rally remains conditional and vulnerable to reversals. Market participants should track remaining congressional hurdles and potential amendments that could narrow the bill's scope.